Brunilde Gril

3.1k total citations · 1 hit paper
30 papers, 1.8k citations indexed

About

Brunilde Gril is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Brunilde Gril has authored 30 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 19 papers in Pulmonary and Respiratory Medicine and 11 papers in Molecular Biology. Recurrent topics in Brunilde Gril's work include Brain Metastases and Treatment (19 papers), HER2/EGFR in Cancer Research (10 papers) and Glioma Diagnosis and Treatment (8 papers). Brunilde Gril is often cited by papers focused on Brain Metastases and Treatment (19 papers), HER2/EGFR in Cancer Research (10 papers) and Glioma Diagnosis and Treatment (8 papers). Brunilde Gril collaborates with scholars based in United States, France and Japan. Brunilde Gril's co-authors include Patricia S. Steeg, Diane Palmieri, Paul R. Lockman, Quentin R. Smith, Helen R. Thorsheim, Kunal S. Taskar, Vinay Rudraraju, Rajendar K. Mittapalli, Seth M. Steinberg and Chris E. Adkins and has published in prestigious journals such as PLoS ONE, JNCI Journal of the National Cancer Institute and Cancer Research.

In The Last Decade

Brunilde Gril

30 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Heterogeneous Blood–Tumor Barrier Permeability Determines Drug Efficacy in Experimental Brain Metastases of Breast Cancer

2010 524 citations Paul R. Lockman, Rajendar K. Mittapalli et al. Clinical Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Brunilde Gril United States	19	951	928	498	481	203	30	1.8k
Helen R. Thorsheim United States	8	553 0.6×	561 0.6×	255 0.5×	326 0.7×	163 0.8×	9	1.1k
Sani H. Kizilbash United States	16	444 0.5×	284 0.3×	453 0.9×	748 1.6×	202 1.0×	76	1.4k
Julie L. Bronder United States	8	804 0.8×	680 0.7×	443 0.9×	294 0.6×	120 0.6×	8	1.4k
Josh Neman United States	17	585 0.6×	441 0.5×	424 0.9×	279 0.6×	256 1.3×	50	1.3k
Sun-Jin Kim United States	27	764 0.8×	626 0.7×	781 1.6×	210 0.4×	74 0.4×	35	1.7k
Jigisha P. Thakkar United States	11	315 0.3×	413 0.4×	412 0.8×	694 1.4×	143 0.7×	26	1.5k
Vinay Rudraraju United States	3	438 0.5×	440 0.5×	224 0.4×	262 0.5×	144 0.7×	3	857
Courtney Kromer United States	5	344 0.4×	505 0.5×	682 1.4×	1.4k 3.0×	191 0.9×	6	2.5k
An Claes Netherlands	13	354 0.4×	253 0.3×	548 1.1×	503 1.0×	115 0.6×	17	1.3k
Kaci A. Bohn United States	9	361 0.4×	394 0.4×	190 0.4×	239 0.5×	190 0.9×	11	825

Countries citing papers authored by Brunilde Gril

Since Specialization

Citations

This map shows the geographic impact of Brunilde Gril's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brunilde Gril with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brunilde Gril more than expected).

Fields of papers citing papers by Brunilde Gril

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brunilde Gril. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brunilde Gril. The network helps show where Brunilde Gril may publish in the future.

Co-authorship network of co-authors of Brunilde Gril

This figure shows the co-authorship network connecting the top 25 collaborators of Brunilde Gril. A scholar is included among the top collaborators of Brunilde Gril based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brunilde Gril. Brunilde Gril is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tran, Andy D., Brunilde Gril, Christina M. Robinson, et al.. (2024). Distinct uptake and elimination profiles for trastuzumab, human IgG, and biocytin-TMR in experimental HER2+ brain metastases of breast cancer. Neuro-Oncology. 26(6). 1067–1082. 2 indexed citations

Khan, Imran, Brunilde Gril, Anurag N. Paranjape, et al.. (2023). Comparison of Three Transcytotic Pathways for Distribution to Brain Metastases of Breast Cancer. Molecular Cancer Therapeutics. 22(5). 646–658. 3 indexed citations

Khan, Imran, Brunilde Gril, Ayuko Hoshino, et al.. (2022). Metastasis suppressor NME1 in exosomes or liposomes conveys motility and migration inhibition in breast cancer model systems. Clinical & Experimental Metastasis. 39(5). 815–831. 7 indexed citations

Zimmer, Alexandra S., Seth M. Steinberg, Dee Dee Smart, et al.. (2020). Temozolomide in Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases. Future Oncology. 16(14). 899–909. 21 indexed citations

Khan, Imran, Brunilde Gril, & Patricia S. Steeg. (2019). Metastasis Suppressors NME1 and NME2 Promote Dynamin 2 Oligomerization and Regulate Tumor Cell Endocytosis, Motility, and Metastasis. Cancer Research. 79(18). 4689–4702. 40 indexed citations

Greer, Yoshimi Endo, Samuel F. Gilbert, Brunilde Gril, et al.. (2019). MEDI3039, a novel highly potent tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptor 2 agonist, causes regression of orthotopic tumors and inhibits outgrowth of metastatic triple-negative breast cancer. Breast Cancer Research. 21(1). 27–27. 48 indexed citations

Lyle, L. Tiffany, Paul R. Lockman, Chris E. Adkins, et al.. (2016). Alterations in Pericyte Subpopulations Are Associated with Elevated Blood–Tumor Barrier Permeability in Experimental Brain Metastasis of Breast Cancer. Clinical Cancer Research. 22(21). 5287–5299. 120 indexed citations

Samala, Ramakrishna, Helen R. Thorsheim, Kunal S. Taskar, et al.. (2016). Vinorelbine Delivery and Efficacy in the MDA-MB-231BR Preclinical Model of Brain Metastases of Breast Cancer. Pharmaceutical Research. 33(12). 2904–2919. 23 indexed citations

Palmieri, Diane, Renata Duchnowska, Stephan Woditschka, et al.. (2014). Profound Prevention of Experimental Brain Metastases of Breast Cancer by Temozolomide in an MGMT-Dependent Manner. Clinical Cancer Research. 20(10). 2727–2739. 45 indexed citations

10.

Gril, Brunilde, Diane Palmieri, Yongzhen Qian, et al.. (2013). Pazopanib Inhibits the Activation of PDGFRβ-Expressing Astrocytes in the Brain Metastatic Microenvironment of Breast Cancer Cells. American Journal Of Pathology. 182(6). 2368–2379. 48 indexed citations

11.

Taskar, Kunal S., Vinay Rudraraju, Rajendar K. Mittapalli, et al.. (2011). Lapatinib Distribution in HER2 Overexpressing Experimental Brain Metastases of Breast Cancer. Pharmaceutical Research. 29(3). 770–781. 160 indexed citations

12.

Gril, Brunilde, Diane Palmieri, Yong Qian, et al.. (2011). The B-Raf Status of Tumor Cells May Be a Significant Determinant of Both Antitumor and Anti-Angiogenic Effects of Pazopanib in Xenograft Tumor Models. PLoS ONE. 6(10). e25625–e25625. 16 indexed citations

13.

Lockman, Paul R., Rajendar K. Mittapalli, Kunal S. Taskar, et al.. (2010). Heterogeneous Blood–Tumor Barrier Permeability Determines Drug Efficacy in Experimental Brain Metastases of Breast Cancer. Clinical Cancer Research. 16(23). 5664–5678. 524 indexed citations breakdown →

14.

Gril, Brunilde, et al.. (2010). Translational research in brain metastasis is identifying molecular pathways that may lead to the development of new therapeutic strategies. European Journal of Cancer. 46(7). 1204–1210. 50 indexed citations

15.

Vogel, Charles, et al.. (2010). Management of ErbB2-positive Breast Cancer: Insights from Preclinical and Clinical Studies with Lapatinib. Japanese Journal of Clinical Oncology. 40(11). 999–1013. 19 indexed citations

16.

Gril, Brunilde, Sylvie Dufour, Réda Hadj-Slimane, et al.. (2008). Capns1, a new binding partner of RasGAP-SH3 domain in K-RasV12 oncogenic cells: Modulation of cell survival and migration. Cellular Signalling. 20(11). 2119–2126. 15 indexed citations

17.

Gril, Brunilde, Dario Palmieri, Julie L. Bronder, et al.. (2008). Effect of Lapatinib on the Outgrowth of Metastatic Breast Cancer Cells to the Brain. JNCI Journal of the National Cancer Institute. 100(15). 1092–1103. 218 indexed citations

18.

Gril, Brunilde, Diane Palmieri, Eleazar Vega-Valle, et al.. (2007). Lapatinib prevents the metastatic colonization of EGFR+ and Her-2+ breast cancer cells in the brain.. Cancer Research. 67. 4081–4081. 4 indexed citations

19.

Gril, Brunilde, Michel Vidal, Franck Assayag, et al.. (2007). Grb2‐SH3 ligand inhibits the growth of HER2⁺ cancer cells and has antitumor effects in human cancer xenografts alone and in combination with docetaxel. International Journal of Cancer. 121(2). 407–415. 36 indexed citations

20.

Gril, Brunilde, Wang‐Qing Liu, C. Lenoir, Christiane Garbay, & Michel Vidal. (2006). Affinity chromatography for purification of the modular protein growth factor receptor-bound protein 2 and development of a screening test for growth factor receptor-bound protein 2 Src homology 3 domain inhibitor using peroxidase-linked ligand. Analytical Biochemistry. 351(1). 93–99. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact